Phase I and pharmacokinetic study of paclitaxel in combination with biricodar, a novel agent that reverses multidrug resistance conferred by overexpression of both MDR1 and MRP
(Q54125043)
scientific article published on September 1, 1998
scientific article published on September 1, 1998
Language:
other details
description | scientific article published on September 1, 1998 |
External Links
(P356) |
10.1200/JCO.1998.16.9.2964
|
(P698) |
9738565
|